Technical Analysis for LUNG - Pulmonx Corporation

Grade Last Price % Change Price Change
F 45.17 4.88% 2.10
LUNG closed down 0.94 percent on Monday, April 12, 2021, on 1.82 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical LUNG trend table...

Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness 4.88%
Wide Bands Range Expansion 4.88%
Down 3 Days in a Row Weakness 4.88%
Oversold Stochastic Weakness 4.88%
Wide Bands Range Expansion 3.89%
Outside Day Range Expansion -0.79%
Wide Bands Range Expansion -0.79%
Wide Bands Range Expansion -2.55%
Wide Bands Range Expansion -2.55%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.54%
Older End-of-Day Signals for LUNG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance about 2 hours ago
Rose Above 10 DMA about 3 hours ago
Up 5% about 4 hours ago
60 Minute Opening Range Breakout about 4 hours ago
Rose Above Previous Day's High about 4 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Pulmonx Corporation Description

Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in Europe, the Middle East, Africa, the Asia-Pacific, the United States, and internationally. Pulmonx Corporation was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City, California.


Sector: Other
Industry: Other
Keywords: Medicine Clinical Medicine Medical Technology Catheter Inflation Pulmonary Disease Chronic Obstructive Pulmonary Disease Tomography Pulmonology Balloon Catheter Chronic Obstructive Pulmonary Diseases Treatment Of Chronic Obstructive Pulmonary Disease Invasive Medical Devices Lung Minimally Invasive Medical Devices Valves

Is LUNG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 69.48
52 Week Low 37.64
Average Volume 288,051
200-Day Moving Average 0.00
50-Day Moving Average 54.36
20-Day Moving Average 49.75
10-Day Moving Average 45.47
Average True Range 3.59
ADX 17.87
+DI 15.18
-DI 27.31
Chandelier Exit (Long, 3 ATRs ) 53.07
Chandelier Exit (Short, 3 ATRs ) 51.75
Upper Bollinger Band 60.21
Lower Bollinger Band 39.29
Percent B (%b) 0.18
BandWidth 42.04
MACD Line -3.22
MACD Signal Line -2.83
MACD Histogram -0.3957
Fundamentals Value
Market Cap 1.54 Billion
Num Shares 35.7 Million
Price-to-Sales 52.65
Price-to-Book 41.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.61
Resistance 3 (R3) 46.65 45.50 46.02
Resistance 2 (R2) 45.50 44.60 45.49 45.82
Resistance 1 (R1) 44.29 44.04 43.72 44.25 45.63
Pivot Point 43.14 43.14 42.86 43.13 43.14
Support 1 (S1) 41.93 42.24 41.36 41.89 40.51
Support 2 (S2) 40.78 41.68 40.77 40.32
Support 3 (S3) 39.57 40.78 40.12
Support 4 (S4) 39.53